(Wall Street Journal) – Hims and other telehealth firms make finasteride easy to get and don’t have to disclose side effects in ads

Finasteride, the generic name for Propecia, is a popular hair-loss treatment that has been on the market for three decades with potential side effects including sexual dysfunction and depression. But a new generation of young men are discovering the medicine—and its potential risks.

That is largely because they are peppered with ads on social media pitching hair-loss medications from telehealth companies, which unlike drugmakers aren’t required to disclose side effects and other risks in advertisements. (Read More)